date,title,source
Oct-17-18,FDA Grants Breakthrough Therapy Designation to Kadmon's KD025 for Chronic Graft-Versus-Host Disease,GlobeNewswire
Oct-18-18,"Detailed Research: Economic Perspectives on Control4, REGENXBIO, Ferro, Kadmon, Hemispherx BioPharma, and Murphy Oil  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Oct-24-18,Kadmon Announces CFO Transition and Other Updates,GlobeNewswire
Oct-25-18,Kadmon Initiates Pivotal Phase 2 Trial of KD025 in Chronic Graft-Versus-Host Disease,GlobeNewswire
Nov-01-18,Kadmon Announces Oral Presentation on KD025 in Chronic Graft-Versus-Host Disease at ASH Annual Meeting,GlobeNewswire
Nov-06-18,Kadmon Presents New Preclinical Data on its Immuno-Oncology Fusion Protein at SITC Annual Meeting,GlobeNewswire
Nov-07-18,Kadmon to Present at the Jefferies 2018 London Healthcare Conference,GlobeNewswire
Nov-09-18,Kadmon Provides Business Update and Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-28-18,"Consolidated Research: 2018 Summary Expectations for Kadmon, Overstock, AECOM, Steelcase, CorMedix, and Corindus Vascular Robotics  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Nov-29-18,Kadmon Presents Data on New ROCK Inhibitor Clinical Candidate at Anti-Fibrotic Drug Development Summit,GlobeNewswire
Dec-03-18,Kadmon Announces Updated Findings from Ongoing Phase 2 Clinical Trial of KD025 in cGVHD at ASH Annual Meeting,GlobeNewswire
Dec-27-18,Kadmon Chairman Bart M. Schwartz to Step Down from Board,GlobeNewswire
Jan-04-19,Kadmon Announces Appointment of Tasos G. Konidaris as Interim Chairman of the Board,GlobeNewswire
Jan-23-19,Kadmon Announces Appointment of Cynthia Schwalm to Board of Directors,GlobeNewswire
